Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. The Contribution of Routinely Collected Clinical Data to Dementia Identification in Primary Care: A Cross-Sectional Study 2026-10-28
  2. Racial Differences and Temporal Trends in Parkinson’s and Alzheimer’s Disease-Related 2026-10-24
  3. Prognostic heterogeneity within cognitive stages: a nationwide cohort study of everyday functional difficulties and mortality in 202,508 older adults 2026-10-23

Studies

265 studies carry this tag.

Date range

1989 to 2026

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 38
  • Journal of the American Geriatrics Society 21
  • medRxiv 19
  • Journal of Alzheimer's disease : JAD 15
  • Research Square 15

104 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. The economic burden of dementia in low- and middle-income countries (LMICs): a systematic review

    ✓ Peer-reviewed alzhub usefulness score 74 out of 100. BMJ global health 2022-04-01 Costs and economics

    The estimated costs of dementia in LMICs are lower than in high-income countries.

  2. Trends in US Medicare Decedents' Diagnosis of Dementia From 2004 to 2017

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. JAMA health forum 2022-04-01 Costs and economics

    Among the included 3 515 329 Medicare fee-for-service decedents, when adjusted for age and sex, the percentage of older decedents with an ADRD diagnosis increased from 34.7% in 2004 to 47.2% in 2017.

  3. Health Care Utilization and Out-of-Pocket Payments among Elderly with Cognitive Frailty in Malaysia

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. International journal of environmental research and public health 2022-03-13 Costs and economics

    In total, 1006 elderly were interviewed, with a 66.18% response rate.

  4. Out-of-pocket costs attributable to dementia: A longitudinal analysis

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Journal of the American Geriatrics Society 2022-03-12 Costs and economics

    We identified a cohort of 3619 incident dementia cases, 38.9% were male, and 66.9% were non-Hispanic White.

  5. The China Alzheimer Report 2022

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. General psychiatry 2022-03-11 Disparities

    China's population has rapidly aged over the recent decades of social and economic development as neurodegenerative disorders have proliferated, especially Alzheimer's disease (AD) and related dementias (ADRD).

  6. Association Between Socioeconomic Disadvantage and Decline in Function, Cognition, and Mental Health After Critical Illness Among Older Adults : A Cohort Study

    ✓ Peer-reviewed alzhub usefulness score 67 out of 100. Annals of internal medicine 2022-03-08 Digital health tools

    Dual-eligible older persons are at greater risk for decline in function and cognition after an ICU hospitalization than their more advantaged counterparts.

  7. Economic Evaluation of Healthcare Resource Utilization and Costs for Newly Diagnosed Dementia-Related Psychosis

    ✓ Peer-reviewed alzhub usefulness score 57 out of 100. Geriatrics (Basel, Switzerland) 2022-03-08 Costs and economics

    This retrospective cohort study described changes in all-cause healthcare resource utilization (HCRU) and associated costs in dementia patients newly diagnosed with psychosis.

  8. Assessments of the Value of New Interventions Should Include Health Equity Impact

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. PharmacoEconomics 2022-03-03 Disparities

    A formal evaluation of the health equity impact of a new intervention is hardly ever performed as part of a health technology assessment to understand its value.

  9. Racial/ethnic disparities in initiation and persistent use of anti-dementia medications

    ✓ Peer-reviewed alzhub usefulness score 61 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2022-02-25 Disparities

    Outcomes for acetylcholinesterase inhibitor (AChEI) treatment included (1) any new AChEI treatment during follow-up, and (2) persistence of treatment during follow-up categorized into: intermittent treatment (< 50% follow-ups reporting treatment), persistent (≥50% follow-ups), and always treated.

  10. Medicare Beneficiary Factors Associated with Skilled Nursing Facility Lengths of Stay

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Journal of applied gerontology : the official journal of the Southern Gerontological Society 2022-01-27 Costs and economics

    The objectives of this study are (1) to identify beneficiary-level characteristics associated with skilled nursing facility (SNF) length of stay (LOS), and (2) to determine if significant differences in LOS exist for vulnerable populations at the individual level or among nursing homes that serve a disproportionate share of vulnerable populations.

  11. Estimated Annual Spending on Aducanumab in the US Medicare Program

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. JAMA health forum 2022-01-14 Costs and economics

    This cross-sectional study examines upper bound and lower bound annualized Medicare costs for administering aducanumab to beneficiaries with the approved indications of mild cognitive impairment or mild dementia.

  12. Racial/Ethnic Disparities in Length of Life after Dementia Diagnosis: an 18-Year Follow-up Study of Medicare Beneficiaries

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Lancet regional health. Americas 2022-01-08 Disparities

    Hispanics and Asians diagnosed with dementia had 40% lower mortality risk and African Americans had 13% lower mortality risk than Whites.

  13. Association of Dementia Severity and Caregiver Support With Early Discharge From Home Health

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. American journal of Alzheimer's disease and other dementias 2022 Caregiving

    The final cohort consisted of 91 302 Medicare beneficiaries with an ADRD diagnosis.

  14. Blood Tests for Alzheimer's Disease: Increasing Efforts to Expand and Diversify Research Participation Is Critical for Widespread Validation and Acceptance

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Journal of Alzheimer's disease : JAD 2022 Biomarkers

    The recent academic and commercial development, and regulatory approvals, of blood-based Alzheimer's disease (AD) biomarkers are breakthrough developments of immense potential.

  15. Diabetes duration and the risk of dementia: a cohort study based on German health claims data

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. Age and ageing 2022-01-01 Digital health tools

    We identified a non-linear association of type 2 diabetes duration and the risk of dementia.

  16. Periodontal Disease and Risk of Dementia in Medicare Patients with Hepatitis C Virus

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Journal of Alzheimer's disease : JAD 2022 Costs and economics

    Of 439,760 HCV patients, the incidence rate of ADRD was higher in patients with periodontal diseases compared to those without (10.84% versus 9.26%, p < 0.001), and those with periodontal disease developed ADRD earlier compared to those without periodontal disease (13.99 versus 21.60 months, p < 0.001).

  17. Risk of Alzheimer's Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching

    ✓ Peer-reviewed alzhub usefulness score 62 out of 100. Journal of Alzheimer's disease : JAD 2022-01-01 Digital health tools

    This study demonstrates that influenza vaccination is associated with reduced AD risk in a nationwide sample of US adults aged 65 and older.

  18. Toward a broader concept of societal value: family spillovers in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. International journal of technology assessment in health care 2021-12-20 Costs and economics

    Recognizing that the "healthcare sector perspective" can be too limited in some situations, the National Institute of Health and Care Excellence (NICE), Institute for Clinical and Economic Review (ICER), and the U.S. Second Panel on Cost-Effectiveness in Health and Medicine all recommend a "societal" perspective in "reference case" cost-effectiveness analyses (CEAs).

  19. Comparison of rates of dementia among older adult recipients of two, one, or no vaccinations

    ✓ Peer-reviewed alzhub usefulness score 62 out of 100. Journal of the American Geriatrics Society 2021-12-12 Digital health tools

    Receiving two types of vaccinations versus one type was associated with lower dementia risk.

  20. Contribution of socioeconomic, lifestyle, and medical risk factors to disparities in dementia and mortality

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. SSM - population health 2021-12-09 Disparities

    Extensive literature in the United States documents racial/ethnic and gender disparities in the incidence and prevalence of dementia yet few studies have examined how race/ethnicity and gender intersect to shape inequalities in the risk of dementia.

  21. Total cost of care increases significantly from early to mild Alzheimer's disease: 5-year ALSOVA follow-up

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Age and ageing 2021-11-10 Caregiving

    Total cost of care in early stage AD (CDR-SB ≤ 4) was 16,448€ (95% CI 13,722-19,716) annually.

  22. This study evaluates whether patients enrolled in trials of aducanumab, EMERGE and ENGAGE, were representative of patients with dementia enrolled in Medicare by estimating the proportions of Medicare beneficiaries with Alzheimer disease (AD) or mild cognitive impairment (MCI) who would have been excluded from these trials.

  23. Health-economic burden of dementia in South Korea

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. BMC geriatrics 2021-10-13 Digital health tools

    The burden of dementia in Korea is expected to considerably increase alongside the elderly population in the future.

  24. Expected wait times for access to a disease-modifying Alzheimer's treatment in the United States

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2021-09-27 Biomarkers

    Better diagnostic tools at initial evaluation may reduce unnecessary delays in access to treatment.

  25. Medical and nursing home costs: From cognitively unimpaired through dementia

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2021-09-05 Costs and economics

    Costs/follow-up day distributions differed significantly across cognitive categories.

  26. Savings and outcomes under Medicare's bundled payments initiative for skilled nursing facilities

    ✓ Peer-reviewed alzhub usefulness score 68 out of 100. Journal of the American Geriatrics Society 2021-08-11 Costs and economics

    Our sample included 1001 participating and 3873 matched control SNFs.

  27. The prevalence and incidence of early-onset dementia among adults with autism spectrum disorder

    ✓ Peer-reviewed alzhub usefulness score 69 out of 100. Autism research : official journal of the International Society for Autism Research 2021-08-11 Digital health tools

    The prevalence and incidence of early-onset dementia among adults with autism spectrum disorder (ASD) is currently unknown.

  28. Repetitive Traumatic Brain Injury Among Older Adults

    ✓ Peer-reviewed alzhub usefulness score 70 out of 100. The Journal of head trauma rehabilitation 2021-07-26 Costs and economics

    A total of 38 064 older Medicare beneficiaries experienced a TBI.

  29. Disparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease Trial

    ✓ Peer-reviewed alzhub usefulness score 67 out of 100. JAMA network open 2021-07-01 Treatments

    Racial/ethnic groups differed in sources of recruitment, reasons for screen failure, and overall probability of eligibility in a preclinical AD trial.

  30. Screening for IC impairments identifies older adults at higher risk of incident frailty and incident IADL/ADL disability.

  31. Advance care planning among Medicare beneficiaries with dementia undergoing surgery

    ✓ Peer-reviewed alzhub usefulness score 73 out of 100. Journal of the American Geriatrics Society 2021-05-20 Costs and economics

    ACP billing codes from 6 months before to 6 months after admission for inpatient surgery.

  32. Dementia Incidence, Burden and Cost of Care: A Filipino Community-Based Study

    ✓ Peer-reviewed alzhub usefulness score 82 out of 100. Frontiers in public health 2021-05-14 Costs and economics

    The crude incidence rate was 16 (CI: 13-20) cases per 1,000 person-years (pyr) with 17 (CI: 12-21) per 1,000 pyr for females and 14 (CI: 9-21) per 1,000 pyr for males.

  33. Memory care approaches to better leverage capacity of dementia specialists: a narrative synthesis

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Neurodegenerative disease management 2021-05-10 Health systems and care delivery

    Prior research suggests that a scarcity of dementia specialists could hamper access to disease-modifying Alzheimer's treatments.

  34. Comparison of dementia risk after age 50 between individuals with and without HIV infection

    ✓ Peer-reviewed alzhub usefulness score 69 out of 100. AIDS (London, England) 2021-04-01 Digital health tools

    Compared with PWOH, PWH were at 58% higher risk for dementia despite HIV treatment with ART.

  35. Smoking and Alcohol Consumption Following a New Dementia Diagnosis

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. The journals of gerontology. Series B, Psychological sciences and social sciences 2021-03-14 Prevention and risk

    Older adults with a new dementia diagnosis were 2.8 times more likely to reduce alcohol consumption than those without such a diagnosis.

  36. Marital loss and risk of dementia: Do race and gender matter?

    ✓ Peer-reviewed alzhub usefulness score 57 out of 100. Social science & medicine (1982) 2021-03-02 Disparities

    Recent studies have found that marital loss through divorce or widowhood is associated with a higher risk of dementia for older adults.

  37. Financial Presentation of Alzheimer Disease and Related Dementias

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. JAMA internal medicine 2021-02-01 Digital health tools

    Alzheimer disease and related dementias were associated with adverse financial events years prior to clinical diagnosis that become more prevalent after diagnosis and were most common in lower-education census tracts.

  38. Traumatic Spinal Cord Injury and Risk of Early and Late Onset Alzheimer's Disease and Related Dementia: Large Longitudinal Study

    ✓ Peer-reviewed alzhub usefulness score 69 out of 100. Archives of physical medicine and rehabilitation 2021-01-27 Digital health tools

    Adults with TSCI are at a heightened risk for ADRD.

  39. Economic Burden of Alzheimer's Disease Dementia in Japan

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Journal of Alzheimer's disease : JAD 2021 Costs and economics

    The total healthcare cost of ADD was JPY 1,073 billion, of which 86% (JPY 923 billion) was attributed to healthcare costs other than ADD drug costs (JPY 151 billion).

  40. Successful Discharge to Community Gap of FFS Medicare Beneficiaries With and Without ADRD Narrowed

    ✓ Peer-reviewed alzhub usefulness score 64 out of 100. Journal of the American Geriatrics Society 2020-12-10 Costs and economics

    Successful discharge of beneficiaries with ADRD increased from 43.4% in 2007 to 53.9% in 2015 (average annual percent change (AAPC) = 2.1 (95% CI = 2.0-2.2)); those without ADRD also increased (from 59.1% to 63.6%, AAPC = 0.9 (95% CI = 0.7-1.1)) but not as fast as those with ADRD (P < .01).

  41. Racial/Ethnic Differences in Health-Related Quality of Life in Persons With and Without Dementia

    ✓ Peer-reviewed alzhub usefulness score 70 out of 100. Journal of the American Geriatrics Society 2020-11-12 Disparities

    Generally, Blacks and Latinos reported higher prevalence of poor HRQOL compared with whites.

  42. Black-White Disparities in Moves to Assisted Living and Nursing Homes Among Older Medicare Beneficiaries

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. The journals of gerontology. Series B, Psychological sciences and social sciences 2020-10-16 Health systems and care delivery

    Black older adults are less likely to move to assisted living and are more likely to move to a nursing home compared to white older adults.

  43. Using Medicare claims in identifying Alzheimer's disease and related dementias

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2020-10-08 Costs and economics

    We found that four items-a Medicare claim recording ADRD 1 year ago, 2 years ago, 3 years ago, and a total stay of 6 months in a nursing home-exhibit a pattern of association consistent with a single underlying ADRD construct, and presence of any two of these four items predict a direct measure of cognitive function and also future claims for ADRD.

  44. Developments in the Market for Assisted Living: Residential Care Availability in 2017

    ✓ Peer-reviewed alzhub usefulness score 54 out of 100. Journal of the American Medical Directors Association 2020-09-29 Health systems and care delivery

    In comparison to counties with the lowest AL penetration, high-penetration counties had higher high school and college education attainment (mean 25.3% vs 18.5%) and median annual income ($56,000 vs $46,800), and lower poverty (12.8% vs 17.3%) and unemployment rates (3.9% vs 5.1%).

  45. [Dementia prevention and primary care: Estimation of the target population]

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Fortschritte der Neurologie-Psychiatrie 2020-09-02 Risk factors

    In a sample of 2,398,405 patients receiving primary care, the target population relevant for dementia prevention measures in 2018 consisted of 191,883 patients with hypertension, 23,308 with obesity, 5,059 with hearing loss, 120,200 with diabetes and 43,233 with depression.

  46. Perspective on the "African American participation in Alzheimer disease research: Effective strategies" workshop, 2018

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2020-08-17 Disparities

    The Washington University School of Medicine Knight Alzheimer Disease Research Center's "African American Participation in Alzheimer Disease Research: Effective Strategies" Workshop convened to address a major limitation of the ongoing scientific progress regarding Alzheimer's disease and related dementias (ADRD): participants in most ADRD research programs overwhelmingly have been limited to non-Hispanic white persons, thus precluding knowledge as to how ADRD may be represented in non-white individuals.

  47. Direct Medical Costs of Dementia With Lewy Bodies by Disease Complexity

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Journal of the American Medical Directors Association 2020-08-06 Costs and economics

    In both databases, total healthcare resource utilization and costs increased with number of core features.

  48. Measuring dementia incidence within a cohort of 267,153 older Australians using routinely collected linked administrative data

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Scientific reports 2020-05-29 Digital health tools

    To estimate dementia incidence rates using Australian administrative datasets and compare the characteristics of people identified with dementia across different datasets.

  49. Racial and Ethnic Differences in Knowledge About One's Dementia Status

    ✓ Peer-reviewed alzhub usefulness score 70 out of 100. Journal of the American Geriatrics Society 2020-04-13 Disparities

    Among subjects identified as having dementia by the prediction model, 43.5% to 50.2%, depending on the survey year, reported that they were informed of the dementia status by their physician.

  50. Receipt of Eye Care Services among Medicare Beneficiaries with and without Dementia

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. Ophthalmology 2020-02-25 Brain scans and imaging

    A total of 4 451 200 beneficiaries met inclusion criteria; 3 805 718 (85.5%) received eye care during the study period, and 391 556 (8.8%) had diagnosed dementia.

From across this tag

8 of the 265 studies in this tag, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 8. The same 8 appear here every time.

All topic tags with their study counts